About the Event
This activity explores the varying levels of obesity. This activity covers research on mechanisms of action of metabolic surgery, their RCTs that inform the question of where such operations fit in the overall treatment algorithm for type 2 diabetes and obesity, and how new data from those RCTs has led to policy changes pertaining to surgery that are evolving based on recommendations from the Diabetes Surgery Summit (DSS-2) consensus conference.
TARGET AUDIENCE
This activity is designed to meet the educational needs of Primary Care Physicians and Endocrinologists who regularly are asked to treat and manage overweight and obese patients. This information is also intended to help PCPs and Endos refer patients with the right BMI range to bariatric surgeon for improved care and resolution of comorbidities.
ACTIVITY GOAL
This activity is designed to address the following core and team competencies: Patient Care and Medical Knowledge.
LEARNING OBJECTIVES
At the conclusion of this course, the participants will be able to:
- Discuss the weight-independent mechanisms mediating remission of type 2 diabetes after selected types of bariatric/metabolic surgery.
- Describe recent Level 1 evidence from randomized clinical trials directly comparing surgical vs. non-surgical approaches to diabetes care, including among patients with a baseline BMI <35 kg/m2.
- Identify new policy changes from the 2nd Diabetes Surgery Summit and the American Diabetes Association advocating consideration of metabolic surgery to treat patients with inadequately controlled type 2 diabetes and a BMI as low as 30 kg/m2, or 27.5 kg/m2 for Asians.
